How "immunomodulatory" are IMIDs?

被引：11

作者：

Mitsiades, Constantine S. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02215 USA

来源：

BLOOD | 2011年 / 117卷 / 05期

关键词：

MULTIPLE-MYELOMA; LENALIDOMIDE; THALIDOMIDE;

D O I：

10.1182/blood-2010-11-317156

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1440 / 1441

页数：3

共 10 条

[1] Lenalidomide and thalidomide: An evolving paradigm for the management of multiple myeloma - Introduction [J].

Anderson, KC ;

Prince, HM .

SEMINARS IN HEMATOLOGY, 2005, 42 (04) :S1-S2

[2]

Attal, 2010, J CLIN ONCOL, V28, P4402

[3] Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma [J].

Davies, FE ;

Raje, N ;

Hideshima, T ;

Lentzsch, S ;

Young, G ;

Tai, YT ;

Lin, B ;

Podar, K ;

Gupta, D ;

Chauhan, D ;

Treon, SP ;

Richardson, PG ;

Schlossman, RL ;

Morgan, GJ ;

Muller, GW ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2001, 98 (01) :210-216

[4]

Gandhi AK, 2010, CURR CANCER DRUG TAR, V10, P155

[5] The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy [J].

Hsu, Andy K. ;

Quach, Hang ;

Tai, Tsin ;

Prince, H. Miles ;

Harrison, Simon J. ;

Trapani, Joseph A. ;

Smyth, Mark J. ;

Neeson, Paul ;

Ritchie, David S. .

BLOOD, 2011, 117 (05) :1605-1613

[6] Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma [J].

Lacy, Martha Q. ;

Hayman, Suzanne R. ;

Gertz, Morie A. ;

Dispenzieri, Angela ;

Buadi, Francis ;

Kumar, Shaji ;

Greipp, Philip R. ;

Lust, John A. ;

Russell, Stephen J. ;

Dingli, David ;

Kyle, Robert A. ;

Fonseca, Rafael ;

Bergsagel, P. Leif ;

Roy, Vivek ;

Mikhael, Joseph R. ;

Stewart, A. Keith ;

Laumann, Kristina ;

Allred, Jacob B. ;

Mandrekar, Sumithra J. ;

Rajkumar, S. Vincent .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5008-5014

[7] Phase III intergroup study of lenalfdomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104 [J].

McCarthy, P. L. ;

Owzar, K. ;

Anderson, K. C. ;

Hofmeister, C. C. ;

Hassoun, H. ;

Hurd, D. D. ;

Stadtmauer, E. A. ;

Giralt, S. ;

Hars, V. ;

Linker, C. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[8] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial [J].

Rajkumar, S. Vincent ;

Jacobus, Susanna ;

Callander, Natalie S. ;

Fonseca, Rafael ;

Vesole, David H. ;

Williams, Michael E. ;

Abonour, Rafat ;

Siegel, David S. ;

Katz, Michael ;

Greipp, Philip R. .

LANCET ONCOLOGY, 2010, 11 (01) :29-37

[9] Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma [J].

Richardson, Paul ;

Jagannath, Sundar ;

Hussein, Mohamad ;

Berenson, James ;

Singhal, Seema ;

Irwin, David ;

Williams, Stephanie F. ;

Bensinger, William ;

Badros, Ashraf Z. ;

Vescio, Robert ;

Kenvin, Laurie ;

Yu, Zhinuan ;

Olesnyckyj, Marta ;

Zeldis, Jerome ;

Knight, Robert ;

Anderson, Kenneth C. .

BLOOD, 2009, 114 (04) :772-778

[10] Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma [J].

Richardson, Paul G. ;

Weller, Edie ;

Jagannath, Sundar ;

Avigan, David E. ;

Alsina, Melissa ;

Schlossman, Robert L. ;

Mazumder, Amitabha ;

Munshi, Nikhil C. ;

Ghobrial, Irene M. ;

Doss, Deborah ;

Warren, Diane L. ;

Lunde, Laura E. ;

McKenney, Mary ;

Delaney, Carol ;

Mitsiades, Constantine S. ;

Hideshima, Teru ;

Dalton, William ;

Knight, Robert ;

Esseltine, Dixie-Lee ;

Anderson, Kenneth C. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) :5713-5719

← 1 →